Evaluating the attractiveness of the terminal oxidases as drug targets in mycobacterium abscessus
The global incidence and prevalence of rapidly-growing mycobacteria (RGM) have increased at a startling rate, particularly in the developed countries. Among them is the Mycobacterium abscessus (Mabs) complex which accounts for the majority of RGM-related infections. Mabs primarily causes pulmonary...
Saved in:
Main Author: | Sorayah, Ria |
---|---|
Other Authors: | Kevin Pethe |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/155733 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Insights into the mechanism, structure and potential as drug target of the mycobacterial bd-type terminal oxidase
by: Ekaterina, Sviriaeva
Published: (2022) -
The Qcrb inhibitors TB47 and telacebec do not potentiate the activity of clofazimine in mycobacterium abscessus
by: Sorayah, Ria, et al.
Published: (2022) -
Drug discovery to reverse clarithromycin resistance in multidrug-resistant mycobacterium abscessus
by: Dam, Linh Chi
Published: (2019) -
Naturally-occurring polymorphisms in QcrB are responsible for resistance to Telacebec in Mycobacterium abscessus
by: Sorayah, Ria, et al.
Published: (2021) -
Terminal oxidases as potential drug targets in mycobacteria
by: Foo, Joan Yuan Zhen
Published: (2016)